Filter
368
Filtered Results: 368
Text search:
Revised
National
TB
Control
Programme,
Ministry
of
Health
India
Featured
Recommendations
34
New Publications
148
Language
Document type
No document type
262
Studies & Reports
38
Guidelines
36
Manuals
14
Strategic & Response Plan
9
Training Material
5
Situation Updates
4
Countries / Regions
India
93
Nepal
22
Myanmar / Burma
15
Global
11
Bangladesh
10
Nigeria
9
Uganda
9
Malawi
7
South–East Asia Region
7
Kenya
6
Ethiopia
5
Sierra Leone
4
Asia
4
Tanzania
4
South Africa
4
Indonesia
4
Senegal
3
Mozambique
3
Cambodia
3
Liberia
3
Pakistan
3
Thailand
2
Rwanda
2
Zimbabwe
2
Africa
2
Latin America and the Carribbean
2
Congo, Democratic Republic of
2
Western and Central Europe
2
East and Southern Africa
2
Namibia
2
Botswana
2
Zambia
2
Colombia
1
Timor Leste/ East Timor
1
Lesotho
1
Laos
1
Afghanistan
1
Philippines
1
Guinea
1
West and Central Africa
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
North America
1
Maldives
1
Argentina
1
Vietnam
1
Eastern Europe
1
Sri Lanka
1
Sudan
1
Georgia
1
Central African Republic
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
86
Policies
29
Studies & Reports
27
Guidelines
24
Capacity Building
21
Community Health
14
Drugs & Medical Equipment
10
HIV & STI
9
TB
8
Hepatitis
7
Women & Child Health
5
Health Systems
5
Bacteriology
4
Countries
4
Demograhic Health Surveys DHS
4
Statistics
4
Infection Control & Prevention (IPC)
3
COVID-19
2
Community Health
2
Pediatrics
2
Medical Devices & Equipment
2
General Guidelines
2
Global Health
2
Communicable Diseases
1
Paediatrics
1
Public Health
1
Family Planning
1
Sanitation
1
Under-5 nutrition
1
Child Health
1
Taeniasis/ Cysticercosis
1
Humanitarian Aid
1
Laboratory Waste
1
Vector Control
1
Monitoring & Evaluation
1
Palliative Care
1
Cervical Cancer
1
Virology
1
Public Health
1
Vaccine-preventable Diseases
1
Information, Education and Communication (IEC)
1
Disabilities
1
Humanitarian Crisis
1
Palliative Care
1
Waste Management
1
Respiratory Infections
1
Gynaecology & Obstetrics
1
Leprosy
1
Women & Child Health
1
Maternal Health
1
Primary Health Care
1
Leishmaniasis
1
Non-communicable Diseases
1
Laboratory Quality Assurance
1
Water
1
Neonatal Care
1
Key Resources
1
Reproductive Health
1
Radiology and Diagnostic
1
Toolboxes
Prevention & Control
16
Detection & Diagnosis
10
Advocacy & Communication
7
Drug resistant TB
7
Antiretroviral Treatment ART
7
HIV in Key Populations
7
Adults
6
Treatment Guidelines HIV
6
Disease Prevention & Control
6
SEAR (South-east Asia Region)
6
Clinical Aspects, Treatment & Prevention
5
Country specific
5
Reports & Studies
5
Opportunistic Infections
4
TB & Other Vulnerable Populations
4
General
4
Global Impact: Socio-economic, health services, TB & HIV
4
Hospital Readiness/Essential Health Services
4
Handbooks & Manuals
4
Midwives
4
HIV &TB
4
Hepatitis
3
HIV
3
Others
3
Country Specific
3
General Information & Methodology
3
Research & Access
3
TB/HIV Coinfection
3
South-east Asia Region
3
Lobby and Advocacy
3
ART Drug Resistance
2
General Reports
2
Childhood TB
2
Treatment & Prevention
2
HIV surveillance
2
Children & Adolescents
2
Curricula & Core Competencies
2
Children
2
Workplace
2
International
2
Laboratory
2
Diagnostics & Laboratory Guidance
2
TB/HIV
2
TB/COVID-19
2
Epilepsy
2
Studies & Reports
2
Women
2
Asia and Pacific
2
Policies and guidelines
2
TB & Prisoners
2
Reports & Studies Children HIV
2
Epidemiology
2
Global Health Ethics
2
Eastern Europe and central Asia
2
Africa
1
Drugs
1
Policies & Strategies
1
Meningitis Prevention & Control
1
Surveillance
1
TB & Drug Abuse
1
Laboratory Guidance
1
Children with Disabilities
1
HIV testing & services
1
Clinical Guidelines
1
IPC
1
Surveillance
1
Inclusion
1
Policies & Strategies
1
Clinical Aspects
1
Mental Health
1
Ukraine
1
South Africa
1
WASH
1
Substance Use Disorders, Others
1
Policies
1
Opoids
1
Transgender People
1
National Policies
1
Public Health
1
Laboratory
1
Eastern Europe
1
Men who have sex with men (MSM)
1
TB
1
Global
1
People who injecting Drugs
1
Prophylaxis
1
SOPs
1
Preparedness, Response & Risk Communication
1
Advocacy
1
Laboratory
1
Drug resistance
1
Clinical aspects
1
Epilepsy
1
Reports
1
Sustainable Development Goals
1
Sex Worker
1
Key Resources
1
Climate & Health
1
Clinical Guidelines
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
Supporting tools
1
Studies
1
Public Health
1
Infection Control General
1
Country specific documents
1
Human Rights
1
Gender Aspects
1
Physical Distancing
1
Situation Reports COVID-19
1
Waste Management
1
Ethics
1
Studies & Reports
1
Community Health Workers CHW
1
Nurses
1
Palliative Care
1
Colombia
1
Clean air
1
Rational use of Medicine
1
Cancer
1
General documents One Health
1
Argentina
1
Waste Managment
1
Reports & Studies
1
Ethics
1
Health Care In Conflict Settings
1
Humanitarian Aid Guidelines
1
Clinical Aspects & Diagnostics
1
Studies & Reports
1
Studies & Reports
1
Overview, Studies & Reports
1
Vector control
1
General Information
1
Studies & Reports
1
General
1
Diagnosis
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Asia
1
Botswana
1
Substance Use Disorders & Addiction
1
Malnutrition
1
TB/HIV Global
1
AR (African Region)
1
Training
1
Nutrition
1
Prevention of mother-to-child transmission (PMTCT)
1
Dengue Prevention & Control
1
International
1
General Public
1
Assessment
1
Tobacco
1
Clinical Guidelines
1
Anxiety Disorders
1
HIV service delivery
1
TB
1
Global Health Financing
1
Eastern Europe & Central Asia
1
Capacity Building
1
Universal Health Coverage & Primary Health Care
1
Eastern and Southern Africa
1
Treatment & Clinical Management
1
MSF provides treatment for HIV and tuberculosis (TB) in more than 20 countries around the world. The report Burden sharing or burden shifting? How the HIV/TB response is being derailed examines the situation in nine countries where MSF runs programmes: Central African Republic, Democratic Republic ...
International Journal of Infectious Diseases 32 (2015) 111–117
Accessed November 2017.
These guidelines – an update to the World Health Organization’s 2015 publication Consolidated strategic information guidelines – present a set of essential aggregate indicators and guidance on choosing, collecting and systematically analysing strategic information to manage and monitor the nat...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
(Health Systems in Transition, Vol. 4, No. 3, 2014)
A Step-by-Step Guide.
It is intended for health planners, dengue or vector control programme managers and individuals, nongovernmental organizations (NGOs) and other agencies with interests and/or expertise in developing biological, chemical, environmental and communication interventions to prevent...
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people ...
Modelling the health impacts of disruptions to essential health services during COVID-19 Module 1
Several epidemiological models have been created to assess the potential impact of disruptions to essential health services caused by COVID-19 on morbidity and mortality from conditions other than COVI...
The second edition of the joint WHO, WIPO and WTO
publication “Promoting Access to Medical Technologies
and Innovation: Intersections between public health,
intellectual property and trade” (the Trilateral Study),*
published in 2020, included a special insert mappi...
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative action on TB and comorbidities aims to support coun...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
WHO today released its first roadmap to tackle postpartum haemorrhage (PPH) – defined as excessive bleeding after childbirth - which affects millions of women annually and is the world’s leading cause of maternal deaths.
Despite being preventable and treatable, PPH results in around 70 000 de...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
The workshop aimed to support countries in the prioritization and acceleration of NCD prevention and management with a specific focus on accelerating the prevention and control of hypertension and diabetes, identifying the most impactful NCD interventions within their context, closing the gaps in ca...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
